Clinical Trial Update: Comparison of TPV/r to DRV/r in Triple Class Experienced Patient With Resistance to > 1 PI [Phase 3]

View source ↗

Summary

Phase 3 study comparing tipranavir/ritonavir (TPV/r) with darunavir/ritonavir (DRV/r) in heavily treatment-experienced HIV patients with resistance to multiple …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• darunavir/ritonavir (DRV/r) (darunavir/ritonavir)
• tipranavir/ritonavir (TPV/r) (tipranavir/ritonavir)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections | Phase 3 | Status: TERMINATED | Results posted: 2009-10-23